|
Volumn 6, Issue 2, 2012, Pages 264-265
|
Long term safety and efficacy of H1N1 vaccine in a single-center cohort of IBD patients treated with immunomodulators and/or anti-TNFα biologics
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
AZATHIOPRINE;
INFLIXIMAB;
INFLUENZA VACCINE;
ADULT;
CLINICAL ARTICLE;
COHORT ANALYSIS;
CROHN DISEASE;
DRUG EFFICACY;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
DRUG TOLERABILITY;
FATIGUE;
FEMALE;
FEVER;
FOLLOW UP;
HUMAN;
LETTER;
MALE;
PAIN;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
ULCERATIVE COLITIS;
VACCINATION;
COHORT STUDIES;
COLITIS, ULCERATIVE;
CROHN DISEASE;
FATIGUE;
FEVER;
HEADACHE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 84856705925
PISSN: 18739946
EISSN: 18764479
Source Type: Journal
DOI: 10.1016/j.crohns.2011.12.004 Document Type: Letter |
Times cited : (2)
|
References (4)
|